TMCnet News
PharmaLinkFHI Strengthens Sales and Marketing Initiatives RESEARCH TRIANGLE PARK, N.C. --(Business Wire)-- Sept. 7, 2004 -- PharmaLinkFHI, Inc. (PharmaLink) an eClinical research organization (eCRO) headquartered in Research Triangle Park, NC, today announced the expansion of its business development team with the appointment of two senior executives - Ken Wilson, Vice President, Sales and Marketing, and George Rafols, Director of Sales Channel Management.Mr. Wilson brings a wealth of business development experience to PharmaLink. His career in the pharmaceutical industry began in 1992 with Eli Lilly and Company where he held a number of progressively demanding sales and marketing positions. In 1997, Mr. Wilson joined Merck and Company where he led several unique initiatives including the development of vaccine programs for managed care customers and the launch planning for three mega trials in Merck's hypertension franchise, Cozaar/Hyzaar. Most recently he was an Associate Director in Sales Strategic Planning where he led efforts to integrate proprietary data and technology in the sales and marketing process. At PharmaLink, Mr. Wilson will head up the sales and marketing team, responsible for the company's development goals. "I am excited to be part of an organization that has left the old paradigm of paper-based clinical trials to define the new standard of conducting clinical research in a paperless or eClinical environment," says Mr. Wilson. "As many of our clients can attest, PharmaLink's proven eClinical approach to trial management is inherently smarter and more efficient. Coupled with the remarkable talent within this company, PharmaLink offers its clients an unparalleled level of confidence when they choose an outsourcing partner. PharmaLink is truly an undiscovered gem within the industry...but that won't be for long." Mr. Rafols has been employed in the pharmaceutical and medical device industries since 1985. At Domain Pharma (now Phase Forward) and later at SAS as a Life Science Manager, he was responsible for providing clinical research software solutions to Fortune 500 biopharmaceutical organizations. As Director of Sales Channel Management at PharmaLink, Mr. Rafols will leverage his expertise in providing technology-based solutions with the unique CRO services developed by PharmaLink. He is a key addition as PharmaLink expands its base of customers seeking the efficiencies and management decision-making benefits associated with conducting trials electronically and accessing real-time data. "The expansion of PharmaLink's business development team is key to meeting the rapidly growing demand within the biopharmaceutical and medical device industries for electronically supported, comprehensive clinical research services," says Albert Siemens, Chief Executive Officer. "Ken Wilson's understanding of pharmaceutical product development and consultative selling to major corporations coupled with George Rafols' specialized insights into the application of technologies to drive organizational efficiencies will be a tremendous asset to PharmaLink and its clients." About PharmaLinkFHI PharmaLink is a new breed of clinical research organization that manages Phase I-IV clinical trials and post-marketing programs online in real time. From protocol development through final clinical study report, PharmaLink integrates deep clinical know-how with industry leading technologies, engaging the entire clinical team with actionable intelligence for more confident decision-making and risk management. Biopharmaceutical organizations look to PharmaLink's proven approach to support and streamline the drug development process. Last year PharmaLink was named a Rising Star on the Deloitte Technology Fast 500, a ranking of the 500 fastest growing technology companies in North America. A special category, the Rising Star list ranks 25 winners that have been in business less than five years, but at least three years. For more information on PharmaLink, visit our web site at www.pharmalinkfhi.com. |
